A copy number pipeline, which employs GRIDSS [53] for joint structural variation calling, confirmed a multiexon in-frame deletion of BRCA1 (chr17:43,096,222–43108182del, p.(K45_S198delinsN)) in all sequenced tumor samples from this patient (Fig. 9). This evidence concerns the gene BRCA1 and neoplasm.